Table 7. Summary of unfavorable outcomes at day 90 after randomization of patients with confirmed West Nile virus in study of treatments for West Nile virus central nervous system disease*.
| Regimen |
No. (%) patients |
Odds ratio (95% CI) |
||
|---|---|---|---|---|
| Favorable |
Unfavorable |
Missing |
||
| Omr-IgG-am, n = 33 | 15 (45.5) | 17 (51.5) | 1 (3.0) | Referent |
| Polygam, n = 11 | 5 (45.5) | 6 (54.5) | 0 | 1.012 (0.198–4.975) |
| Normal saline, n = 11 |
8 (72.7) |
3 (27.3) |
0 |
3.238 (0.606–21.959) |
| Total confirmed, n = 55 | 28 (50.9) | 26 (47.2) | 1 (1.8) | |
*Favorable/unfavorable determinations made on the basis of results of 4 standardized assessments of cognitive and functional status: Barthel Index (favorable >90, unfavorable <90), Modified Rankin Scale (favorable 0–3, unfavorable 4–6), Glasgow Outcome Score (favorable 4 or 5, unfavorable <4), and the Modified Mini Mental State Examination (favorable >78, unfavorable <78).